Diagnostic Tools for Necrotizing Enterocolitis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial evaluates the effectiveness of two imaging methods for diagnosing necrotizing enterocolitis (NEC) in newborns. One group will receive an abdominal X-ray, while the other will undergo both an X-ray and a bowel ultrasound. The trial aims to determine which method performs better across different newborn intensive care units (NICUs). Babies in the NICU showing signs of NEC, who require further imaging as determined by their doctor, may be suitable candidates. As an unphased trial, this study provides an opportunity to contribute to important research that could enhance diagnostic methods for newborns.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these diagnostic tools are safe for evaluating NEC in NICU settings?
Research has shown that abdominal X-rays, often used to diagnose necrotizing enterocolitis (NEC), are generally safe. However, they involve radiation exposure, which requires consideration, especially if multiple X-rays are needed over time.
Bowel ultrasound (BUS) is another method under study for NEC. Studies have demonstrated that BUS is safe and does not use radiation. It can detect signs of NEC, such as bowel wall thickening and gas, before they appear on X-rays, making it a promising tool for early detection.
Both methods are commonly used in medical settings to diagnose conditions like NEC, and significant negative effects specifically related to these methods have not been reported.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores advanced diagnostic tools for necrotizing enterocolitis, a serious condition in newborns. Current standard methods often rely heavily on clinical signs and imaging like abdominal X-rays, which can sometimes miss early signs of the disease. This trial investigates whether combining abdominal radiographs with bowel ultrasounds offers a more precise and earlier diagnosis. By using ultrasound, which can provide real-time images and detailed views of bowel structure and blood flow, doctors aim to catch the condition sooner, potentially leading to faster and more effective interventions.
What evidence suggests that this trial's diagnostic tools could be effective for evaluating NEC?
Research shows that abdominal X-rays are commonly used to diagnose necrotizing enterocolitis (NEC), but they have limitations, especially for early detection. In this trial, participants will follow different diagnostic approaches. One group will use abdominal radiographs alone, while another will combine abdominal radiographs with bowel ultrasound (BUS). Studies suggest that BUS might be more effective for early NEC diagnosis. Specifically, one study found that BUS is highly accurate, with a sensitivity of 75% and a specificity of 97.6%. BUS has proven better than X-rays at identifying early signs of NEC, such as bowel wall thickening and gas in the portal vein. Overall, BUS may offer a more reliable tool for early NEC detection compared to traditional X-rays.23678
Who Is on the Research Team?
Sherwin Chan, MD PhD
Principal Investigator
Children's Mercy Kansas City
Are You a Good Fit for This Trial?
This trial is for preterm infants born at or before 32 weeks' gestation, who are in the NICU at CMKC or KUMC and suspected of having Necrotizing Enterocolitis (NEC) needing further imaging. Infants with major gastrointestinal anomalies like gastroschisis or omphalocele that prevent bowel ultrasound (BUS) cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-study Training
Pre-study training for sonographers and radiologists to standardize BUS image acquisition and interpretation
Treatment
Participants undergo either abdominal radiograph alone or abdominal radiograph plus bowel ultrasound for NEC evaluation
Follow-up
Participants are monitored for safety and effectiveness after imaging procedures
What Are the Treatments Tested in This Trial?
Interventions
- Abdominal radiograph
- Bowel Ultrasound
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Mercy Hospital Kansas City
Lead Sponsor
University of Kansas Medical Center
Collaborator
American College of Radiology
Collaborator